FI915646A0 - Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,11-tetrahydrobentso[6,7]syklo-okta[1,2-b]tiofeeni-6,11-imiinien ja 6,11-dihydrobentso[6,7]syklo-okta[1,2-b]tiofeeni-6,11-imiinien valmistamiseksi ja siinä käyttökelpoinen välituoteyhdiste - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,11-tetrahydrobentso[6,7]syklo-okta[1,2-b]tiofeeni-6,11-imiinien ja 6,11-dihydrobentso[6,7]syklo-okta[1,2-b]tiofeeni-6,11-imiinien valmistamiseksi ja siinä käyttökelpoinen välituoteyhdiste

Info

Publication number
FI915646A0
FI915646A0 FI915646A FI915646A FI915646A0 FI 915646 A0 FI915646 A0 FI 915646A0 FI 915646 A FI915646 A FI 915646A FI 915646 A FI915646 A FI 915646A FI 915646 A0 FI915646 A0 FI 915646A0
Authority
FI
Finland
Prior art keywords
cycloocta
imines
thiophene
useful
compounds
Prior art date
Application number
FI915646A
Other languages
English (en)
Swedish (sv)
Other versions
FI98462C (fi
FI98462B (fi
Inventor
Ralph P Robinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI915646A0 publication Critical patent/FI915646A0/fi
Application granted granted Critical
Publication of FI98462B publication Critical patent/FI98462B/fi
Publication of FI98462C publication Critical patent/FI98462C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Luminescent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI915646A 1989-06-01 1991-11-29 Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,11-tetrahydrobentso[6,7]syklo-okta[1,2-b]tiofeeni-6,11-imiinien ja 6,11-dihydrobentso[6,7]syklo-okta[1,2-b]tiofeeni-6,11-imiinien valmistamiseksi ja siinä käyttökelpoinen välituoteyhdiste FI98462C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1989/002387 WO1990015060A1 (en) 1989-06-01 1989-06-01 4,5,6,11-TETRAHYDROBENZO[6,7]CYCLOOCTA[1,2-b]THIOPHEN-6,11-IMINES AND 6,11-DIHYDROBENZO[6,7]CYCLOOCTA[1,2-b]THIOPHEN-6,11-IMINES
US8902387 1989-06-01

Publications (3)

Publication Number Publication Date
FI915646A0 true FI915646A0 (fi) 1991-11-29
FI98462B FI98462B (fi) 1997-03-14
FI98462C FI98462C (fi) 1997-06-25

Family

ID=22215050

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915646A FI98462C (fi) 1989-06-01 1991-11-29 Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,11-tetrahydrobentso[6,7]syklo-okta[1,2-b]tiofeeni-6,11-imiinien ja 6,11-dihydrobentso[6,7]syklo-okta[1,2-b]tiofeeni-6,11-imiinien valmistamiseksi ja siinä käyttökelpoinen välituoteyhdiste

Country Status (11)

Country Link
EP (1) EP0400916B1 (fi)
JP (1) JPH0662630B2 (fi)
AT (1) ATE113950T1 (fi)
CA (1) CA2017911A1 (fi)
DE (1) DE69013983T2 (fi)
DK (1) DK0400916T3 (fi)
ES (1) ES2063266T3 (fi)
FI (1) FI98462C (fi)
IE (1) IE64909B1 (fi)
PT (1) PT94205B (fi)
WO (1) WO1990015060A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196415A (en) * 1989-05-09 1993-03-23 The United States Of America As Represented By The Department Of Health And Human Services 5-aminocarbonyl-5H-dibenzo[a.d]cyclohepten-5,10-imines for treatment of epilepsy and cocaine addiction
US5260309A (en) * 1989-06-01 1993-11-09 Pfizer Inc. 4,5,6,11-tetrahydrobenzo [6,7] cycloocta [1,2-b]thiophen-6,11-imines and 6,11-dihydrobenzo [6,7] cycloocta [1,2-b] thiophen-6,11-imines
GB9002834D0 (en) * 1990-02-08 1990-04-04 Ici America Inc Compounds
US6413410B1 (en) 1996-06-19 2002-07-02 Lifescan, Inc. Electrochemical cell

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3816455A (en) * 1971-04-23 1974-06-11 Mcneilab Inc Certain benzothiepino-indoles and indoline-thiochromans
US4112110A (en) * 1974-02-22 1978-09-05 Ciba-Geigy Corporation Oxygenated azatetracyclic compounds
US4414154A (en) * 1977-09-19 1983-11-08 Merck & Co. Inc. Dibenzo[a,d]cycloocten-5,12-imines
NL7808848A (nl) * 1977-09-19 1979-03-21 Merck & Co Inc Dibenzoa.dcyclo-octeen-5.12-(en 6.12)-iminen.
US4252810A (en) * 1978-11-15 1981-02-24 Merck & Co., Inc. 9,10-Dihydro-4H-benzo[4,5]cyclohepta [1,2-b]thiophen-4,9-imines

Also Published As

Publication number Publication date
WO1990015060A1 (en) 1990-12-13
EP0400916B1 (en) 1994-11-09
ES2063266T3 (es) 1995-01-01
PT94205B (pt) 1997-01-31
EP0400916A2 (en) 1990-12-05
JPH0662630B2 (ja) 1994-08-17
FI98462C (fi) 1997-06-25
CA2017911A1 (en) 1990-12-01
DE69013983D1 (de) 1994-12-15
ATE113950T1 (de) 1994-11-15
JPH0320278A (ja) 1991-01-29
PT94205A (pt) 1991-02-08
DE69013983T2 (de) 1995-03-16
IE901951L (en) 1990-12-01
FI98462B (fi) 1997-03-14
IE64909B1 (en) 1995-09-20
EP0400916A3 (en) 1991-11-27
DK0400916T3 (da) 1994-12-05

Similar Documents

Publication Publication Date Title
PT1029853E (pt) Derivados biciclicos heteroaromaticos uteis como agentes anticancerigenos
YU224790A (sh) Aminokarbonil karbamati, sorodni fizostigminu/in postopek za njihovo pripravo in njihova uporaba kot zdravila
FI93117C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi
FI915646A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,11-tetrahydrobentso[6,7]syklo-okta[1,2-b]tiofeeni-6,11-imiinien ja 6,11-dihydrobentso[6,7]syklo-okta[1,2-b]tiofeeni-6,11-imiinien valmistamiseksi ja siinä käyttökelpoinen välituoteyhdiste
FI900365A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-fenyyli-5,6-dihydrobents/C/akridiini-7-karboksyylihappojohdannnaisten valmistamiseksi
DE69222570T2 (de) Phosphonsäurederivate, Verfahren zur Herstellung und ihre Verwendung
BR9502079A (pt) Composto,formulação farmaceutica e processo para preparar um composto
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
FI891155A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroisotiatsolo/4,5-c/pyridiini-johdannaisten ja niiden isomeerien ja happoadditiosuolojen valmistamiseksi
HU9401968D0 (en) Pharmaceutical compositions and process for producing them
DK424888A (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
PL300155A1 (en) Method of obtaining 3-amino pyroles non-substituted at their 1 position

Legal Events

Date Code Title Description
BB Publication of examined application